Scientists investigating drug therapies for children with Acute Lymphoblastic Leukaemia (ALL) have presented new data demonstrating for the very first time that a small molecule called ABT-737 can increase the effectiveness of standard therapies.
Pediatrics researchers at The Children?s Hospital of Philadelphia and McGill University in Montreal have identified a gene variant that raises a child?s risk for type 1 diabetes, formerly called juvenile diabetes.
Researchers at Johns Hopkins University have found that symptoms in patients with obstructive sleep apnea and hypopnea can be significantly reduced through treatment with nasal insufflation, using a nasal cannula to deliver warm, humidified air at a high flow rate.
A new study from the Harvard School of Public Health (HSPH) shows that patients who go to hospitals ranked higher according to specific quality measures have a lower chance of dying than patients treated at lower-ranked hospitals.
Make it an even decade. National Jewish Medical and Research Center has been named the best respiratory hospital in the nation by U.S. News & World Report for the tenth year in a row. The ranking is part of the 2007 “America’s Best Hospitals” guide published by the weekly newsmagazine.
City of Hope has been named one of ?America?s Best Hospitals? in two specialties by U.S.News & World Report. City of Hope ranked 30th on this year?s list of top cancer hospitals and 29th on the list for urology.
About 3 of every 10 children and teens who are admitted to the hospital from the emergency room have asthma, pneumonia, acute bronchitis or another respiratory disorder, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Rochester has become one of only a handful of communities around the world to offer a genetic test to detect Batten disease, a deadly inherited disorder.
ValleyCare Health System and UCSF have signed a letter of intent to enhance health care services for women and children in the Tri-Valley region of the East Bay.
The number of lymph nodes that contain evidence of cancer is the best predictor of the effectiveness of adding chemotherapy and radiation to a treatment plan prior to surgery in individuals with oesophageal cancer, according to a study published last month in the Annals of Surgery.